Skip to main content
. 2022 Mar;30(1):18–24. doi: 10.5455/aim.2022.30.18-24

Table 2. General characteristics of patients in the study groups.

General characteristics
Indicators CG (n=201) IG (n=224) Total (n=425) p- value
Age (avr.+ SD) 62.8±4.1 63.9±2.9 62.4±3.9
Female (n,%) 124 (61.7) 67 (29.9) 191 (44.9) ≤0.001
Male (n,%) 77 (38.3) 157 (70.1) 234 (55.1) ≤0.001
Period of illness (AH) (n,%)
≥ 1 year 3 (1.5) 7 (3.1) 10 (2.4)
≥ 3 years 12 (6.0) 6 (2.7) 18 (4.2) ≤0.05
≥ 5 years 42 (20.9) 32 (14.3) 74 (17.4)
≥ 10 years 144 (71.6) 179 (79.9) 323 (76.0)
Dyslipidemia (n,%) 120 (59.7) 145 (64.7) 265 (62.4)
Body mass index (n,%)
<25 17 (8.5) 71 (31.7) 88 (20.7) ≤ 0.001
25-29,9 98 (48.7) 112 (50.0) 210 (49.4) ≤0.05
> 30 86 (42.8) 41 (18.3) 127 (29.8) ≤0.001
Diabetes (n,%) 51 (25.4) 28 (12.5) 79(18.6) ≤0.05
Smoking (n,%)
no 176 (87.5) 184 (82.1) 360 (84.7)
previous 14 (7.0) 16 (7.1) 30 (7.1)
current 11 (5.5) 24 (10.7) 35 (8.2) ≤ 0.05
History of CVD (n,%) 34 (16.9) 26 (11.6) 60 (14.1)
History of AF (n,%) 42 (20.9) 29 (12.9) 71 (16.7) ≤0.05
24 hour BP (mm Hg; Wed + SD) 168.4±21.2 / 92.1±14.3 163.3±17.8 / 90.4±15.5 165.1±24.1 / 90.8±11.7
Daytime blood pressure (mm Hg / Wed + SD) 174.3±19.7 / 98.3±11.5 170.1±17.4 / 95.3±10.9 172.4±18.4 / 97.1±12.4
AH–arterial hypertension; history of CVD–cardiovascular disease (acute coronary syndrome, stroke); AF–atrial fibrillation